We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
ENDRA Life Sciences Inc | NASDAQ:NDRA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.0078 | 2.54% | 0.3149 | 0.3012 | 0.315 | 0.334 | 0.30 | 0.334 | 115,011 | 00:42:34 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒ | |
| |
Filed by a Party other than the Registrant ☐ | |
| |
Check the appropriate box: | |
| |
☐ | Preliminary Proxy Statement |
|
|
☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|
|
☐ | Definitive Proxy Statement |
|
|
☒ | Definitive Additional Materials |
|
|
☐ | Soliciting Material Pursuant to Rule 14a-12 |
ENDRA LIFE SCIENCES INC. |
(Name of Registrant as Specified in its Charter) |
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
☒ | No fee required. |
|
|
☐ | Fee paid previously with preliminary materials. |
|
|
☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
2 |
3 |
1 Year ENDRA Life Sciences Chart |
1 Month ENDRA Life Sciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions